259 related articles for article (PubMed ID: 27689878)
1. Deficiency of Parkinson's disease-related gene Fbxo7 is associated with impaired mitochondrial metabolism by PARP activation.
Delgado-Camprubi M; Esteras N; Soutar MP; Plun-Favreau H; Abramov AY
Cell Death Differ; 2017 Jan; 24(1):120-131. PubMed ID: 27689878
[TBL] [Abstract][Full Text] [Related]
2. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function.
Navarro E; Esteras N
FEBS J; 2024 Jun; 291(12):2562-2564. PubMed ID: 38708447
[TBL] [Abstract][Full Text] [Related]
3. Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.
Teixeira FR; Randle SJ; Patel SP; Mevissen TE; Zenkeviciute G; Koide T; Komander D; Laman H
Biochem J; 2016 Oct; 473(20):3563-3580. PubMed ID: 27503909
[TBL] [Abstract][Full Text] [Related]
4. The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.
Burchell VS; Nelson DE; Sanchez-Martinez A; Delgado-Camprubi M; Ivatt RM; Pogson JH; Randle SJ; Wray S; Lewis PA; Houlden H; Abramov AY; Hardy J; Wood NW; Whitworth AJ; Laman H; Plun-Favreau H
Nat Neurosci; 2013 Sep; 16(9):1257-65. PubMed ID: 23933751
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiological mechanisms linking F-box only protein 7 (FBXO7) and Parkinson's disease (PD).
Zhou ZD; Lee JCT; Tan EK
Mutat Res Rev Mutat Res; 2018; 778():72-78. PubMed ID: 30454685
[TBL] [Abstract][Full Text] [Related]
6. Structure and Function of Fbxo7/PARK15 in Parkinson's Disease.
Randle SJ; Laman H
Curr Protein Pept Sci; 2017; 18(7):715-724. PubMed ID: 26965690
[TBL] [Abstract][Full Text] [Related]
7. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
[TBL] [Abstract][Full Text] [Related]
8. Impaired mitochondrial accumulation and Lewy pathology in neuron-specific FBXO7-deficient mice.
Noda S; Sato S; Fukuda T; Ueno S; Tada N; Hattori N
Mol Brain; 2022 Jun; 15(1):54. PubMed ID: 35701754
[TBL] [Abstract][Full Text] [Related]
9. FBXO7 Y52C polymorphism as a potential protective factor in Parkinson's disease.
Chen CM; Chen IC; Huang YC; Juan HF; Chen YL; Chen YC; Lin CH; Lee LC; Lee CM; Lee-Chen GJ; Lai YJ; Wu YR
PLoS One; 2014; 9(7):e101392. PubMed ID: 25029497
[TBL] [Abstract][Full Text] [Related]
10. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
11. Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.
Lehmann S; Costa AC; Celardo I; Loh SH; Martins LM
Cell Death Dis; 2016 Mar; 7(3):e2166. PubMed ID: 27031963
[TBL] [Abstract][Full Text] [Related]
12. FBXO7 triggers caspase 8-mediated proteolysis of the transcription factor FOXO4 and exacerbates neuronal cytotoxicity.
Lee SH; Jung S; Lee YJ; Hyun M; Chung KC
J Biol Chem; 2021 Dec; 297(6):101426. PubMed ID: 34800438
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of FBXO7 and its role in human diseases.
Zhong Y; Li J; Ye M; Jin X
Gene; 2023 Jan; 851():146972. PubMed ID: 36261086
[TBL] [Abstract][Full Text] [Related]
14. Glutamate excitotoxicity and Ca2+-regulation of respiration: Role of the Ca2+ activated mitochondrial transporters (CaMCs).
Rueda CB; Llorente-Folch I; Traba J; Amigo I; Gonzalez-Sanchez P; Contreras L; Juaristi I; Martinez-Valero P; Pardo B; Del Arco A; Satrustegui J
Biochim Biophys Acta; 2016 Aug; 1857(8):1158-1166. PubMed ID: 27060251
[TBL] [Abstract][Full Text] [Related]
15. Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.
Cao S; Sun Y; Wang W; Wang B; Zhang Q; Pan C; Yuan Q; Xu F; Wei S; Chen Y
J Cell Mol Med; 2019 Oct; 23(10):6897-6906. PubMed ID: 31379115
[TBL] [Abstract][Full Text] [Related]
16. F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy.
Zhou ZD; Xie SP; Sathiyamoorthy S; Saw WT; Sing TY; Ng SH; Chua HP; Tang AM; Shaffra F; Li Z; Wang H; Ho PG; Lai MK; Angeles DC; Lim TM; Tan EK
Hum Mol Genet; 2015 Nov; 24(22):6314-30. PubMed ID: 26310625
[TBL] [Abstract][Full Text] [Related]
17. E3 ligase adaptor FBXO7 contributes to ubiquitination and proteasomal degradation of SIRT7 and promotes cell death in response to hydrogen peroxide.
Lee SH; Lee YJ; Jung S; Chung KC
J Biol Chem; 2023 Mar; 299(3):102909. PubMed ID: 36646384
[TBL] [Abstract][Full Text] [Related]
18. Glucose deprivation converts poly(ADP-ribose) polymerase-1 hyperactivation into a transient energy-producing process.
Buonvicino D; Formentini L; Cipriani G; Chiarugi A
J Biol Chem; 2013 Dec; 288(51):36530-7. PubMed ID: 24194524
[TBL] [Abstract][Full Text] [Related]
19. Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation.
Broniowska KA; Diers AR; Corbett JA; Hogg N
Biochemistry; 2013 Jun; 52(25):4364-72. PubMed ID: 23718265
[TBL] [Abstract][Full Text] [Related]
20. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease.
Fitzgerald JC; Zimprich A; Carvajal Berrio DA; Schindler KM; Maurer B; Schulte C; Bus C; Hauser AK; Kübler M; Lewin R; Bobbili DR; Schwarz LM; Vartholomaiou E; Brockmann K; Wüst R; Madlung J; Nordheim A; Riess O; Martins LM; Glaab E; May P; Schenke-Layland K; Picard D; Sharma M; Gasser T; Krüger R
Brain; 2017 Sep; 140(9):2444-2459. PubMed ID: 29050400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
